| Axon ID |
Name |
Description |
From price |
|
1386
|
CHIR99021
|
GSK-3 inhibitor |
€60.00 |
|
1484
|
DAPT
|
γ-Secretase inhibitor |
€90.00 |
|
1509
|
LDN 193189 hydrochloride
|
Highly potent small molecule inhibitor of BMP type I receptors ALK2, ALK3, and ALK6 |
€65.00 |
|
1661
|
SB 431542
|
TGF-βR1 inhibitor; ALK inhibitor |
€70.00 |
|
1667
|
SU 5402
|
Fibroblast growth factor receptor (FGFR) inhibitor |
€60.00 |
|
2128
|
Stem Cell 2i inhibitor Set
|
Set of MEK inhibitor PD0325901 (Axon 1408) and GSK-3 inhibitor CHIR99021 (Axon 1386) |
€90.00 |
|
2129
|
Stem Cell 3i inhibitor Set
|
Set of FGFR inhibitor SU5402 (Axon 1667), MEK inhibitor PD184352 (Axon 1368) and GSK-3 inhibitor CHIR99021 (Axon 1386) |
€130.00 |
|
2130
|
Stem Cell Alternative 2i inhibitor Set
|
Set of SRC inhibitor CGP77675 (Axon 2097) and GSK-3 inhibitor CHIR99021 (Axon 1386) |
€110.00 |
|
5004
|
Stem Cell LSB inhibitor Set
|
Set of BMP inhibitor LDN 193189 (Axon 1509) and TGF-β inhibitor SB 431542 (Axon 1661) |
€90.00 |
|
5005
|
Stem Cell LSC inhibitor Set
|
Set of LDN 193189 HCl, SB 431542 and CHIR99021, inhibitors of BMP, TGF-β, and GSK-3 resp. |
€130.00 |
|
5006
|
Stem Cell CSD inhibitor Set
|
Set of CHIR99021, SU5402, and DAPT, inhibitors of GSK-3, FGFR, and γ-secretase, resp. |
€140.00 |
|
5008
|
Stem Cell RG-BIX inhibitor Set
|
Set of RG 108 and BIX 01294 HCl, inhibitors of DNMT and HMTase, respectively |
€60.00 |
|
5009
|
Stem Cell 4i inhibitor Set
|
Set of Thiazovivin, SB 431542, PD0325901, and CHIR99021 (inhibitors of ROCK, TGF-β, MEK, and GSK-3 resp.) |
€170.00 |
|
5010
|
Naive Stem Cell NHSM inhibitor Set
|
Set of inhibitors for isolation, generation, derivatization and stabilization of naive hPSCs |
€230.00 |
|
5011
|
Naive Stem Cell 5i inhibitor Set
|
Set of five inhibitors for the induction and maintenance of human naive stem cell pluripotency |
€200.00 |
|
2849
|
Apatinib
|
Inhibitor of VEGFR2 |
€120.00 |
|
2865
|
NVP-ACC789
|
Inhibitor of VEGFR2 |
€90.00 |
|
2903
|
SJ000291942
|
Activator of the canonical BMP signaling pathway |
€95.00 |
|
2930
|
Alofanib
|
Allosteric inhibitor of FGFR2 |
€90.00 |
|
2943
|
SRI-011381 hydrochloride
|
TGF-β signaling agonist |
€125.00 |
|
2953
|
Roblitinib
|
First-in-class, highly selective and potent FGFR4 inhibitor |
€125.00 |
|
2951
|
XL 388
|
Highly potent, selective, ATP-competitive, and orally bioavailable mTOR inhibitor |
€125.00 |
|
2837
|
BMS 605541
|
Potent, selective, orally active, and ATP-competitive VEGFR2 inhibitor |
€90.00 |
|
3153
|
BRD5648
|
Negative control compound of BRD0705 as a GSK3α inhibitor |
€210.00 |
|
3154
|
rac-BRD0705
|
GSK3α inhibitor |
€140.00 |
|
2931
|
BRD0705
|
First-in-class, paralog selective GSK3α inhibitor |
€210.00 |
|
3404
|
LY-364947
|
Potent, selective and ATP-competitive TGF-βR 1 inhibitor |
€90.00 |
|
3552
|
LDN 212854
|
Potent ALK2-biased BMP type I receptor kinase inhibitor |
€110.00 |
|
3579
|
Tideglusib
|
GSK-3 inhibitor |
€60.00 |
|
3624
|
Toceranib phosphate
|
Multi-targeted receptor tyrosine kinase inhibitor |
€60.00 |
|
3628
|
MHY-1685
|
mTOR inhibitor; Senescence inhibitor |
€50.00 |
|
3892
|
LY-3200882
|
TGF-βR 1 inhibitor |
Inquire |
|
3946
|
Altiratinib
|
Balanced inhibitor for MET, TIE2 (TEK), and VEGFR2 (KDR) kinases |
Inquire |
|
3914
|
CDD-1653
|
First-in-class, highly potent, and selective BMPR2 kinase inhibitor |
€110.00 |
|
3973
|
XL-228
|
Multitargeted protein kinase inhibitor (IGF1R, Aurora,FGFR, ABL,ALK and SRC) |
Inquire |
|
3975
|
MGCD265 dihydrochloride
|
Orally active, potent MET/SMO dual inhibitor |
€130.00 |
|
3996
|
AZD2014
|
Orally bioavailable dual mTORC1/mTORC2 inhibitor |
Inquire |
|
3998
|
MGCD516
|
Orally bioavailable receptor tyrosine kinase (RTK) inhibitor |
Inquire |
|
3936
|
Bisindolylmaleimide I
|
Potent and selective PKC inhibitor |
€120.00 |
|
4165
|
SB4
|
Potent BMP agonist |
Recently added
|
€80.00 |
|
4149
|
Everolimus
|
Selective and orally active mTOR1 inhibitor |
Recently added
|
Inquire |